$247 Million is the total value of FINANCIAL CONSULATE, INC's 121 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -4,000 | -100.0% | -0.09% | – |
RCEL | Exit | AVITA THERAPEUTICS INC | $0 | – | -10,848 | -100.0% | -0.09% | – |
NFLX | Exit | NETFLIX INC | $0 | – | -396 | -100.0% | -0.09% | – |
TENB | Exit | TENABLE HLDGS INC | $0 | – | -7,380 | -100.0% | -0.17% | – |
SPTL | Exit | SPDR SER TRportfolio ln tsr | $0 | – | -146,045 | -100.0% | -2.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-04-19
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SCHWAB STRATEGIC TR | 36 | Q3 2023 | 19.5% |
SCHWAB STRATEGIC TR | 36 | Q3 2023 | 13.1% |
SCHWAB STRATEGIC TR | 36 | Q3 2023 | 16.9% |
ISHARES TR | 36 | Q3 2023 | 3.5% |
SCHWAB STRATEGIC TR | 36 | Q3 2023 | 13.7% |
SCHWAB STRATEGIC TR | 36 | Q3 2023 | 3.4% |
ISHARES TR | 36 | Q3 2023 | 2.9% |
ISHARES TR | 36 | Q3 2023 | 1.0% |
SCHWAB STRATEGIC TR | 35 | Q3 2023 | 20.1% |
ISHARES TR | 35 | Q3 2023 | 1.3% |
View FINANCIAL CONSULATE, INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HARRIS & HARRIS GROUP INC /NY/ | January 20, 2015 | 1,611,466 | 4.9% |
View FINANCIAL CONSULATE, INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-23 |
13F-HR | 2024-02-01 |
13F-HR | 2023-10-24 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-17 |
13F-HR | 2023-01-11 |
13F-HR | 2022-10-20 |
13F-HR | 2022-07-19 |
13F-HR | 2022-04-28 |
13F-HR | 2022-02-07 |
View FINANCIAL CONSULATE, INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.